TherapeuticsMD, Inc. (TXMD): Price and Financial Metrics


TherapeuticsMD, Inc. (TXMD): $1.32

-0.02 (-1.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

TXMD POWR Grades


  • Growth is the dimension where TXMD ranks best; there it ranks ahead of 83.87% of US stocks.
  • TXMD's strongest trending metric is Quality; it's been moving up over the last 31 weeks.
  • TXMD's current lowest rank is in the Momentum metric (where it is better than 5.04% of US stocks).

TXMD Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for TXMD is -7.65 -- better than only 1.54% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -2.34 for TherapeuticsMD Inc; that's greater than it is for just 4.27% of US stocks.
  • TherapeuticsMD Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -26.87%, greater than the shareholder yield of only 9.89% of stocks in our set.
  • Stocks that are quantitatively similar to TXMD, based on their financial statements, market capitalization, and price volatility, are QMCO, AQST, PRTK, AMRS, and OMER.
  • Visit TXMD's SEC page to see the company's official filings. To visit the company's web site, go to www.therapeuticsmd.com.

TXMD Price Target

For more insight on analysts targets of TXMD, see our TXMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.00 Average Broker Recommendation 1.33 (Strong Buy)

TXMD Stock Price Chart Interactive Chart >

Price chart for TXMD

TXMD Price/Volume Stats

Current price $1.32 52-week high $2.75
Prev. close $1.34 52-week low $1.00
Day low $1.28 Volume 5,586,100
Day high $1.38 Avg. volume 11,799,549
50-day MA $1.21 Dividend yield N/A
200-day MA $1.39 Market Cap 519.01M

TherapeuticsMD, Inc. (TXMD) Company Bio


TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, vitamin D supplements, and natural menopause relief products under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company was founded in 2008 and is based in Boca Raton, Florida.


TXMD Latest News Stream


Event/Time News Detail
Loading, please wait...

TXMD Latest Social Stream


Loading social stream, please wait...

View Full TXMD Social Stream

Latest TXMD News From Around the Web

Below are the latest news stories about TherapeuticsMD Inc that investors may wish to consider to help them evaluate TXMD as an investment opportunity.

TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA

TXMD submits supplemental NDA to FDA for low-dose Bijuva

Yahoo | May 25, 2021

The Sun Sentinel Names TherapeuticsMD, Inc. a Winner of the South Florida Top Workplaces 2021 Award

Sun Sentinel names TXMD as Top Workplace Winner

Yahoo | May 24, 2021

TherapeuticsMD Shares Plunge On Declining Gross Margin, Total Prescription Volume

TherapeuticsMD Inc (NASDAQ: TXMD ) reported a Q1 EPS loss of $0.11 better than the analyst consensus estimate loss of $0.12, as well as an improvement from EPS loss of $0.21 a year ago. Sales of $19.90 million were slightly better than the consensus of $19.77 million. Though the sales figure improved 60% Y/Y, it was down 13% sequentially. Annovera's net product … Full story available on Benzinga.com

Benzinga | May 6, 2021

TherapeuticsMD Announces Poster Presentation of ANNOVERA® Data at the American College of Obstetricians and Gynecologists 2021 Annual Meeting

TXMD presents new ANNOVERA data at 2021 Annual Meeting of American College of Obstetrics and Gynecologists

Yahoo | May 3, 2021

Should TherapeuticsMD Be in Your Portfolio?

https://www.investing.com/news/stock-market-news/should-therapeuticsmd-be-in-your-portfolio-2490080

Investing.com | April 29, 2021

Read More 'TXMD' Stories Here

TXMD Price Returns

1-mo 25.71%
3-mo -20.48%
6-mo 8.20%
1-year -3.65%
3-year -80.81%
5-year -84.54%
YTD 9.09%
2020 -50.00%
2019 -36.48%
2018 -36.92%
2017 4.68%
2016 -44.36%

Continue Researching TXMD

Here are a few links from around the web to help you further your research on TherapeuticsMD Inc's stock as an investment opportunity:

TherapeuticsMD Inc (TXMD) Stock Price | Nasdaq
TherapeuticsMD Inc (TXMD) Stock Quote, History and News - Yahoo Finance
TherapeuticsMD Inc (TXMD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.865 seconds.